HTB

2023

WHO endorses “zero” transmission risk for people with HIV with an undetectable viral load

Viral load level when suppressed <1000 predicts future rebound: 3-monthly monitoring required

ART-associated hypertension can be successfully treated in African settings

REPRIEVE study: statin benefits people living with HIV at low to moderate CVD risk

Geneva patient and other HIV cure research at IAS 2023

Guide to other HIV cure-related research at IAS 2023

Rapporteur summaries: track B clinical science

Early press conference: cure, gay circumcision, PrEP choices, mpox, and COVID-19

High rates of occult HBV in Botswana: risks from relying on HBsAg screening

Anal cancer: 1 in 5 risk of missing precancerous lesions if only HSIL are biopsied

29th BHIVA Annual Conference 2023 (BHIVA 2023) – final reports

No vertical HIV transmissions in the UK from women eligible for supported breastfeeding

Adverse birth outcomes with diabetes and hypertensive disorders in pregnancy

CAB-LA receives positive opinion for EU approval as PrEP

New UK vaccine schedule for HPV depends on HIV status

UK shingles vaccine: changes from 1 September 2023

New guidelines on cognitive impairment in people living with HIV

PrEP for women and PrEP: new translations (June 2023)

HTB: no. 7/8 (July/August 2023) PDF download

HTB May/June 2023: HIV and implementation science

Non technical HTB news: 12 stories from May/June issue

New i-Base pocket leaflets (May 2023)

BHIVA Annual Conference 2023 (BHIVA 2023)

UK cascade data cautions UNAIDS 95:95:95 targets: re-engaging people in care

Overview of weight gain, integrase inhibitors and ART

Selected webcasts from BHIVA 2023

30th CROI (CROI 2023): final reports

Viral reservoir increases on long-term ART: new strategies for a cure

Microbiota biomarkers might predict risk of HSIL progression: succinyl-CoA and cobalamin

CROI overviews by BHIVA and IAS-USA

BHIVA guidelines modify assessment of cardiovascular risk (2023)

NHS England approves use of F/TAF as alternative PrEP

BHIVA guidelines on non-TB mycobacteria (NTM)

No benefit on HIV-associated neurocognitive impairment from CNS-penetrating ART

First successful liver transplant from living donor with HIV/HCV coinfection: surgical video online

US studies report mpox vaccine efficacy from single- vs double-dose might only be 36% vs 66%

Review of idiopathic lymphocytopenia

ART increases life expectancy by 30 to 40 years: impact of CD4 count, sex and calendar year

Tracking HIV A6 strain in Europe: implications for injectable CAB-LA for treatment or PrEP

Tenofovir reduces risk of COVID-19 in pre-vaccine studies

HTB: no. 5/6 (May/June 2023) PDF download

Long-term survivors & HIV cure research

HTB: no. 4 (April 2023) PDF download

HTB April 2023 (6 April 2023)

David Wojnarowicz: F**k You F*ggot F**ker – now online

30th CROI (CROI 2023): further reports

IAS-USA update HIV drug resistance tables

Dapivirine ring safe in late pregnancy and during breastfeeding

Implications of restrictions on reproductive rights for HIV care in the USA and beyond

Generic versions of injectable PrEP could enable access to CAB-LA in low-income countries

Statins reduce heart disease by 35% in the international HIV REPRIEVE study

Penile BOTOX injections improve blood flow and other outcomes in men with moderate to severe erectile dysfunction

UK data on efficacy of mpox vaccine: caution needed in observational analyses 

Updates on US mpox research: surveillance, testing, vaccines and research

HIV cures 3, 4 and 5: Düsseldorf case published, City of Hope patient gives public interview, New York case published

Cases of mpox reinfection in HIV negative men on PrEP: atovaquone, mefloquine and molnupiravir as potential treatments

Training webinar: 2nd HIV from A to Z

30th Conference on Retroviruses and OIs (CROI 2023): first reports

HTB March 2023 (10 March 2023)

CROI 2023: Pipeline HIV drugs and formulations for treatment and PrEP

CROI 2023: Six-monthly ART – lenacapavir + dual bNAbs maintains undetectable viral load for 26 weeks after single doses

CROI 2023: Other lenacapavir studies – experienced and naive updates, the dosing window, HIV-2 and PrEP

CROI 2023: Similar PK profile for thigh vs gluteal CAB/RPV-LA injections: accidental intravenous injection

CROI 2023: Efficacy of N6LS monotherapy correlated with baseline factors

CROI 2023: CAB/RPV-LA levels are not reduced after switching from efavirenz

Post navigation